CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis

Journal of Hypertension

Volumn 22, Issue 8, 2004, Pages 1523-1528

  Amar, Jacques ^a,b   Ruidavets, Jean Bernard ^b   Bal Dit Sollier, Claire ^c   Bongard, Vanina ^b   Boccalon, Henri ^a   Chamontin, Bernard ^a   Drouet, Ludovic ^c   Ferrières, Jean ^b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

(C260T) polymorphism; Atherosclerosis; Inflammation; sCD14; Smoking

Indexed keywords

CD14 ANTIGEN;

ADULT; ALLELE; ARTERIOSCLEROSIS; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; DEMOGRAPHY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; SMOKING; STATISTICAL ANALYSIS;

EID: 3843078522     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000133724.16947.a3     Document Type: Article

References (31)

1. Gunn M, Stephens JC, Thompson JR, Rathbone BJ, Samani NJ. Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000; 84:267-271.
2. Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P, et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000; 101:252-257.
3. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973-979.
4. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-126.
5. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431-1433.
6. Kitchens RL, Thompson PA, Viriyakosol S, O'Keefe GE, Munford RS. Plasma CD 14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest 2001; 108:485-493.
7. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993; 90:2744-2748.
8. Amar J, Ruidavets JB, Bal Dit Sollier C, Bongard V, Boccalon H, et al. Soluble CD14 and aortic stiffness in a population-based study. J Hypertens 2003; 21:1869-1877.
9. Hubacek JA, Rothe G, Pit'ha J, Skodova Z, Stanek V, Poledne R, et al. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99:3218-3220.
10. Shimada K, Watanabe Y, Mokuno H, Iwama Y, Daida H, Yamaguchi H. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am J Cardiol 2000; 86:682-684.
11. Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, Haberbosch W. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 1999; 19:932-938.
12. Lichy C, Meiser H, Grond-Ginsbach C, Buggle F, Dorfer C, Grau A. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population. J Neurol 2002; 249:821-823.
13. Zee RY, Lindpaintner K, Struk B, Hennekens CH, Ridker PM. A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction. Atherosclerosis 2001; 154:699-702.
14. Ito D, Murata M, Tanahashi N, Sato H, Sonoda A, Saito I, et al. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke 2000; 31:2661-2664.
15. Nauck M, Winkelmann BR, Hoffmann MM, Bohm BO, Wieland H, Marz WC. (-26O)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Am J Cardiol 2002; 90:1249-1252.
16. Longobardo MT, Cefalu AB, Pezzino F, Noto D, Emmanuele G, Barbagallo CM, et al. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Clin Exp Med 2003; 3:161-165.
17. Koenig W, Khuseyinova N, Hoffmann MM, Marz W, Frohlich M, Hoffmeister A, et al. CD14 C(-260)→T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 2002; 40:34-42.
18. Heesen M, Blomeke B, Schluter B, Heussen N, Rossaint R, Kunz D. Lack of association between the -260C→T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels. Intensive Care Med 2001; 27:1770-1775.
19. Risley P, Jerrard-Dunne P, Sitzer M, Buehler A, Kegler S von, Markus HS. Promoter polymorphism in the endotoxin receptor (CD14) is associated with increased carotid atherosclerosis only in smokers: the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2003; 34:600-604.
20. Ferriéres J, Ruidavets JB. Association between resting heart rate and hypertension treatment in a general population. Am J Hypertens 1999; 12:628-631.
21. Amar J, Ruidavets JB, Chamontin B, Drouet L, Ferrières J. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 2001; 19:381-387.
22. Ferrières J, Elias A, Ruidavets JB, Pous J. Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population. J Hypertens 1999; 17:743-748.
23. Bongard V, Elias A, Bal dit Sollier C, Ruidavets JB, Boccalon H, Drouet L, et al. Soluble intercellular adhesion molecule-1 is associated with carotid and femoral atherosclerosis but not with intima-media thickness in a population-based sample. Atherosclerosis 2002; 164:297-304.
24. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20:976-983.
25. Zalai CV, Kolodziejczyk MD, Pilarski L, Christov A, Nation PN, Lundstrom-Hobman M, et al. Increased circulating monocyte activation in patients with unstable coronary syndromes. J Am Coll Cardiol 2001; 38:1340-1347.
26. Hayashi J, Masaka T, Ishikawa I. Increased levels of soluble CD14 in sera of periodontitis patients. Infect Immun 1999; 67:417-420.
27. Hockertz S, Emmendorffer A, Scherer G, Ruppert T, Daube H, Tricker AR, et al. Acute effects of smoking and high experimental exposure to environmental tobacco smoke (ETS) on the immune system. Cell Biol Toxicol 1994; 10:177-190.
28. Bergmann S, Siekmeier R, Mix C, Jaross W. Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1. Respir Physiol 1998; 114:269-275.
29. Hasday JD, Bascorn R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115:829-835.
30. Eng HL, Chen CH, Kuo CC, Wu JS, Wang CH, Lin TM. Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection. J Infect Dis 2003; 188:90-97.
31. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316:1043-1047.